Erste Asset Management’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-375,000
Closed -$38.1M 624
2025
Q4
$38.1M Sell
375,000
-20,900
-5% -$1.68M 0.32% 77
2025
Q3
$21.1M Sell
395,900
-40,423
-9% -$2.02M 0.2% 119
2025
Q2
$23.2M Buy
436,323
+1,051
+0.2% +$53.4K 0.2% 111
2025
Q1
$18.9M Buy
435,272
+82,491
+23% +$4.18M 0.24% 100
2024
Q4
$19.9M Sell
352,781
-39,358
-10% -$2.45M 0.24% 101
2024
Q3
$26.5M Buy
392,139
+86,007
+28% +$4.85M 0.32% 82
2024
Q2
$13M Sell
306,132
-17,796
-5% -$979K 0.17% 133
2024
Q1
$22.3M Buy
323,928
+41,000
+14% +$2.59M 0.3% 94
2023
Q4
$21M Buy
282,928
+25,000
+10% +$1.64M 0.31% 94
2023
Q3
$17.6M Sell
257,928
-14,862
-5% -$1.26M 0.3% 96
2023
Q2
$25.6M Sell
272,790
-35,212
-11% -$2.75M 0.45% 68
2023
Q1
$20.8M Sell
308,002
-50,876
-14% -$3.27M 0.4% 74
2022
Q4
$17.8M Buy
358,878
+35,905
+11% +$1.47M 0.38% 75
2022
Q3
$10.5M Buy
322,973
+33,026
+11% +$1.36M 0.24% 122
2022
Q2
$11.5M Buy
289,947
+106,447
+58% +$5.69M 0.26% 111
2022
Q1
$12.9M Sell
183,500
-38,400
-17% -$2.81M 0.25% 109
2021
Q4
$17.2M Buy
221,900
+66,000
+42% +$5.82M 0.31% 95
2021
Q3
$14.8M Buy
155,900
+45,000
+41% +$4.75M 0.29% 100
2021
Q2
$13.9M Buy
110,900
+15,000
+16% +$1.79M 0.28% 109
2021
Q1
$12.5M Sell
95,900
-38,000
-28% -$5.2M 0.31% 101
2020
Q4
$18.1M Sell
133,900
-11,400
-8% -$1.38M 0.5% 55
2020
Q3
$14.8M Buy
145,300
+25,000
+21% +$2.16M 0.51% 65
2020
Q2
$10.4M Hold
120,300
0.42% 78
2020
Q1
$6.99M Buy
120,300
+54,000
+81% +$4.38M 0.41% 68
2019
Q4
$6.17M Sell
66,300
-33,500
-34% -$2.95M 0.27% 92
2019
Q3
$9.1M Sell
99,800
-12,000
-11% -$1.37M 0.49% 55
2019
Q2
$13M Hold
111,800
0.69% 34
2019
Q1
$9.58M Buy
111,800
+5,000
+5% +$426K 0.54% 41
2018
Q4
$6.51M Buy
+106,800
New +$7.33M 0.44% 53

Other funds holding EXAS

Erste Asset Management's EXAS Position: Q1 2026 in Review

Erste Asset Management sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 375,000 shares — an estimated $38.1M sold.

Erste Asset Management first reported a position in EXAS in Q4 2018 and held it in 29 quarters. The position peaked at $38.1M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Erste Asset Management reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Erste Asset Management sold 375,000 Exact Sciences shares in Q1 2026, an estimated $38.1M.
  • Erste Asset Management first reported a position in Exact Sciences in Q4 2018 and held it in 29 quarters.
  • Erste Asset Management's Exact Sciences position peaked at $38.1M in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Erste Asset Management's 13F filing for Q1 2026, filed 11 May 2026.